Last reviewed · How we verify

NCT05450913

Frequency of Piriformis Syndrome:Does the Presence of One Pathology Rule Out the Other?

Status unknown NA Last updated 12 July 2022
What this trial tests

NA trial testing Priformis intramuscular injection with %2 lidocain in Chronic Pain in 100 participants. Status unknown.

Timeline
10 July 2022
Primary endpoint
15 July 2022
15 July 2022

Quick facts

Lead sponsorDiskapi Teaching and Research Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment100
Start date10 July 2022
Primary completion15 July 2022
Estimated completion15 July 2022

Drugs / interventions tested

Conditions studied

Sponsor

Diskapi Teaching and Research Hospital

Who can join

Adults 18 to 70, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the investigators is to determine the frequency of priformis syndrome in patients presenting with hip and/or leg pain and to investigate the association of Priformis syndrome with other pathologies of the lumbar spine and hip.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Diskapi Teaching and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05450913.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing